DD291559A5 - Verfahren zur herstellung von 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinen - Google Patents

Verfahren zur herstellung von 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinen Download PDF

Info

Publication number
DD291559A5
DD291559A5 DD90337216A DD33721690A DD291559A5 DD 291559 A5 DD291559 A5 DD 291559A5 DD 90337216 A DD90337216 A DD 90337216A DD 33721690 A DD33721690 A DD 33721690A DD 291559 A5 DD291559 A5 DD 291559A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
hydrogen
formula
nmr
alkyl
Prior art date
Application number
DD90337216A
Other languages
German (de)
English (en)
Inventor
John E Macor
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD291559A5 publication Critical patent/DD291559A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
DD90337216A 1989-01-20 1990-01-19 Verfahren zur herstellung von 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinen DD291559A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000231 WO1990007926A1 (en) 1989-01-20 1989-01-20 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines

Publications (1)

Publication Number Publication Date
DD291559A5 true DD291559A5 (de) 1991-07-04

Family

ID=22214793

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90337216A DD291559A5 (de) 1989-01-20 1990-01-19 Verfahren zur herstellung von 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinen
DD90343473A DD298398A5 (de) 1989-01-20 1990-01-19 Verfahren zur herstellung von zwischenverbindungen fuer 3-(1,2,5,6 -tetrahydropyridyl)-pyrrolopyridinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90343473A DD298398A5 (de) 1989-01-20 1990-01-19 Verfahren zur herstellung von zwischenverbindungen fuer 3-(1,2,5,6 -tetrahydropyridyl)-pyrrolopyridinen

Country Status (26)

Country Link
US (2) US5051412A (fi)
EP (1) EP0379314B1 (fi)
JP (1) JPH0751576B2 (fi)
KR (1) KR920010642B1 (fi)
CN (1) CN1025998C (fi)
AT (1) ATE103282T1 (fi)
CA (1) CA2008016A1 (fi)
CS (1) CS277611B6 (fi)
DD (2) DD291559A5 (fi)
DE (1) DE69007501T2 (fi)
DK (1) DK0379314T3 (fi)
EG (1) EG18945A (fi)
ES (1) ES2062319T3 (fi)
FI (1) FI94641C (fi)
HU (1) HU206349B (fi)
IE (1) IE62757B1 (fi)
IL (1) IL93041A (fi)
MX (1) MX19185A (fi)
MY (1) MY106305A (fi)
NO (1) NO912860D0 (fi)
NZ (1) NZ232166A (fi)
PL (2) PL163626B1 (fi)
PT (1) PT92889A (fi)
WO (1) WO1990007926A1 (fi)
YU (1) YU47553B (fi)
ZA (1) ZA90393B (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX19185A (es) * 1989-01-20 1993-12-01 Pfizer Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
US5451566A (en) * 1993-11-17 1995-09-19 Zeneca Limited Herbicidal pyrrolopyridine compounds
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
ZA979961B (en) * 1996-11-15 1999-05-05 Lilly Co Eli 5-HT1F agonists
EP1082958A3 (en) * 1996-11-15 2002-12-11 Eli Lilly And Company 5-HT1F agonists in chronic pain
EP0875513A1 (en) * 1997-04-14 1998-11-04 Eli Lilly And Company Substituted heteroaromatic 5-HT 1F agonists
US5905084A (en) * 1997-11-14 1999-05-18 Eli Lilly And Company 5-HTIF -agonists effective in treating migraine
ZA989389B (en) * 1997-11-14 2000-04-14 Lilly Co Eli Pyrrolo [3,2-b] pyridine processes and intermediates.
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
WO2004060355A1 (en) 2002-12-26 2004-07-22 Pozen Inc. Multilayer Dosage Forms Containing NSAIDs and Triptans
KR101223914B1 (ko) * 2003-11-21 2013-01-18 어레이 바이오파마 인크. Akt 단백질 키나제 억제제
EP2264033A1 (en) 2004-07-27 2010-12-22 SGX Pharmaceuticals, Inc. 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS
US7626021B2 (en) * 2004-07-27 2009-12-01 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
AU2005269387A1 (en) 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
CN101516891B (zh) 2006-07-06 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的二氢噻吩并嘧啶
RU2481336C2 (ru) 2006-07-06 2013-05-10 Эррэй Биофарма Инк. Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101511842B (zh) 2006-07-06 2012-10-31 阵列生物制药公司 作为akt蛋白激酶抑制剂的二氢呋喃并嘧啶
US8012965B2 (en) 2006-12-29 2011-09-06 Rigel Pharmaceuticals, Inc. Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
BRPI0813993A2 (pt) * 2007-07-05 2015-06-16 Array Biopharma Inc Ciclopentanos de pirimidila como inibidores de proteína quinase akt
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
RU2486181C2 (ru) 2007-07-05 2013-06-27 Эррэй Биофарма Инк. Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
NZ586346A (en) * 2008-01-09 2012-02-24 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
NZ586720A (en) * 2008-01-09 2012-11-30 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
AU2010204578B2 (en) 2009-01-16 2016-05-12 Rigel Pharmaceuticals, Inc. AXL inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
GEP20156325B (en) 2009-06-17 2015-07-10 Vertex Pharma Inhibitors of influenza viruses replication
MX2013006836A (es) 2010-12-16 2013-09-26 Vertex Pharma Inhibidores de la replicacion de los virus de la influenza.
CN103857395A (zh) 2011-04-01 2014-06-11 基因泰克公司 Akt抑制剂化合物和阿比特龙的组合及使用方法
KR20140022053A (ko) 2011-04-01 2014-02-21 제넨테크, 인크. Akt 및 mek 억제제 화합물의 조합물, 및 사용 방법
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3421468B1 (en) 2013-11-13 2020-11-04 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
RS59144B1 (sr) 2013-11-13 2019-09-30 Vertex Pharma Inhibitori replikacije virusa influence
CA2960567C (en) 2014-10-23 2023-03-07 Janssen Pharmaceutica Nv Thienopyrimidine derivatives as nik inhibitors
JP6616412B2 (ja) * 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272804A (en) * 1963-12-23 1966-09-13 Sterling Drug Inc Process and intermediates for preparing indoles
GB1141949A (en) * 1966-02-23 1969-02-05 Sterling Drug Inc 7-azaindole derivatives
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2421899A1 (fr) * 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
FR2444678A2 (fr) * 1978-12-22 1980-07-18 Roussel Uclaf Nouveau procede de preparation de derives du piperidyl-indole et de leurs sels
US5025096A (en) * 1985-08-22 1991-06-18 Mine Safety Appliances Company Preparation of indole and indole derivatives
MX19185A (es) * 1989-01-20 1993-12-01 Pfizer Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.

Also Published As

Publication number Publication date
WO1990007926A1 (en) 1990-07-26
IL93041A (en) 1994-02-27
EP0379314B1 (en) 1994-03-23
KR900011772A (ko) 1990-08-02
CN1025998C (zh) 1994-09-28
MX19185A (es) 1993-12-01
IE900210L (en) 1990-07-23
EP0379314A1 (en) 1990-07-25
US5169947A (en) 1992-12-08
CN1044465A (zh) 1990-08-08
EG18945A (en) 1994-09-29
CS277611B6 (en) 1993-03-17
AU4867390A (en) 1990-07-26
NO912860L (no) 1991-07-22
HU206349B (en) 1992-10-28
ATE103282T1 (de) 1994-04-15
PT92889A (pt) 1990-07-31
NZ232166A (en) 1992-10-28
DK0379314T3 (da) 1994-05-09
PL283354A1 (en) 1991-08-12
YU9990A (en) 1992-05-28
FI913509A0 (fi) 1991-07-22
HUT57762A (en) 1991-12-30
AU613259B2 (en) 1991-07-25
JPH0751576B2 (ja) 1995-06-05
NO912860D0 (no) 1991-07-22
CS26090A3 (en) 1992-02-19
PL287840A1 (en) 1991-07-15
CA2008016A1 (en) 1990-07-20
IL93041A0 (en) 1990-11-05
KR920010642B1 (ko) 1992-12-12
FI94641B (fi) 1995-06-30
ZA90393B (en) 1991-08-28
FI94641C (fi) 1995-10-10
IE62757B1 (en) 1995-02-22
DE69007501T2 (de) 1994-06-30
YU47553B (sh) 1995-10-03
US5051412A (en) 1991-09-24
MY106305A (en) 1995-04-29
DE69007501D1 (de) 1994-04-28
JPH02247175A (ja) 1990-10-02
DD298398A5 (de) 1992-02-20
ES2062319T3 (es) 1994-12-16
PL163626B1 (pl) 1994-04-29

Similar Documents

Publication Publication Date Title
DD291559A5 (de) Verfahren zur herstellung von 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridinen
DE60316542T2 (de) 7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen
DE60315615T2 (de) Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen
DE69909818T2 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
DE60124577T2 (de) Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
DE69911935T3 (de) Granulatimide-derivate zur behandlung von krebs
WO1994018199A1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE102004028973A1 (de) Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE602004005960T2 (de) Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
DE69823493T2 (de) Tetrahydropyridoverbindungen
EP0417631A2 (de) Kondensierte Diazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE60038498T2 (de) Triazole als Farnesyltransferaseinhibitoren
CN111278814B (zh) 作为毒蕈碱m1受体正向别构调节剂的多环酰胺
DE3782636T2 (de) Isoindolin-1-on-derivat und antiarrhythmisches mittel.
DE69232980T2 (de) Pyrroloazepinderivate
EA003991B1 (ru) Производные 2-аминопиридинов, способ ингибирования синтазы оксида азота, фармацевтические композиции и способы лечения
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE60108398T2 (de) Kristallin-therapeutisches mittel
DE2221808C2 (de) Hydrazinopyridazin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und Heilmittel
WO1996003404A1 (de) Acylimidazopyridine
KR100888468B1 (ko) 항암활성을 갖는1'-알킬피페리딘-4'-스피로-2-6-(아미도)-2h-벤조피란유도체
TWI313602B (en) Gyrase inhibitors and uses thereof
SK287216B6 (sk) Hydrochloridová etanolová solvátová forma (-)-cis-2-(2- chlórfenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-metyl)piperidinyl]- 4H-1-benzopyran-4-ónu, spôsob jej prípravy, farmaceutická kompozícia, ktorá ju obsahuje, a jej použitie
CH623591A5 (en) Process for the preparation of ergopeptide alkaloid derivatives
DD296926A5 (de) Neue pyridobenzoindolderivate, ihre herstellung und die sie enthaltenden zusammensetzungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee